Concourse Financial Group Securities, Inc. Heron Therapeutics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$0
Q2 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 100.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$1.72 - $2.42 $0 - $0	0 New	0 $0
Q1 2025 May 14, 2025	SELL	$1.47 - $2.55 $1,881 - $3,264	-1,280 Closed	0 $0
Q3 2024 Oct 10, 2024	SELL	$1.73 - $3.67 $519 - $1,101	-300 Reduced 18.99%	1,280 $2,000
Q3 2023 Oct 25, 2023	SELL	$0.97 - $1.8 $24 - $45	-25 Reduced 1.56%	1,580 $1,000
Q1 2023 May 15, 2023	SELL	$1.51 - $3.25 $2,893 - $6,227	-1,916 Reduced 54.42%	1,605 $2,000
Q4 2022 Jan 30, 2023	BUY	$2.25 - $4.67 $1,246 - $2,587	554 Added 18.67%	3,521 $0
Q3 2022 Nov 15, 2022	BUY	$2.66 - $5.37 $6,780 - $13,688	2,549 Added 609.81%	2,967 $13,000
Q2 2022 Aug 09, 2022	SELL	$2.3 - $6.29 $2,099 - $5,742	-913 Reduced 68.6%	418 $1,000
Q4 2021 Feb 07, 2022	BUY	$8.35 - $12.6 $2,162 - $3,263	259 Added 24.16%	1,331 $12,000
Q3 2021 Nov 09, 2021	BUY	$10.13 - $15.0 $1,975 - $2,925	195 Added 22.23%	1,072 $11,000
Q4 2020 Feb 02, 2021	BUY	$14.61 - $22.14 $1,563 - $2,368	107 Added 13.9%	877 $19,000
Q3 2020 Nov 13, 2020	BUY	$13.67 - $17.77 $560 - $728	41 Added 5.62%	770 $11,000
Q2 2020 Aug 13, 2020	BUY	$10.89 - $21.47 $4,671 - $9,210	429 Added 143.0%	729 $11,000
Q4 2018 Feb 14, 2019	BUY	$22.03 - $32.01 $6,609 - $9,603	300 New	300 $7,000
Q3 2018 Nov 13, 2018	BUY	$30.0 - $40.85 $0 - $0	0 New	0 $0

Others Institutions Holding HRTX

# of Institutions

185

Shares Held

134M

Call Options Held

61.1K

Put Options Held

2.06M

Rubric Capital Management LP New York, NY

29.1M
Shares

$32 Million
0.61% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

10.2M
Shares

$11.3 Million
0.02% of portfolio
Clearline Capital LP New York, NY

9.71M
Shares

$10.7 Million
0.62% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

8.75M
Shares

$9.63 Million
21.67% of portfolio
Vanguard Group Inc Valley Forge, PA

8.46M
Shares

$9.31 Million
0.0% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $131M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account